Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Álvaro Ruiz Granados"'
Autor:
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa
Publikováno v:
Cancer treatment reviews. 105
Thyroid cancer is the most frequently diagnosed endocrine malignancy, with an increasing incidence over the last decades. The recent advances in understanding the molecular mechanisms underlying the carcinogenesis of thyroid cancer have led to a bett
Autor:
Pablo Álvarez Ballesteros, Jesús Chamorro, Álvaro Ruiz Granados, María San Román-Gil, Javier Pozas, Javier Molina-Cerrillo, Victoria Gómez Dos Santos, Teresa Alonso-Gordoa, Enrique Grande
Publikováno v:
Cancers
Cancers, Vol 13, Iss 5981, p 5981 (2021)
Cancers, Vol 13, Iss 5981, p 5981 (2021)
Simple Summary Renal cell carcinoma is particularly characterized by its high vascularization and dense immune cells infiltration. The angiogenesis blockade in combination with immune checkpoint inhibitors have supposed milestones in the treatment la
Autor:
Francesco Massari, Frede Donskov, Stéphane Oudard, Laurence Albiges, Clara Iglesias, Elena Verzoni, Jeffrey Graham, Roberto Llarena, Hardev Pandha, Xavier Garcia del Muro, Giuseppe Procopio, Daniel Castellano, Miguel Angel Climent Duran, Oscar Reig, Michele De Tursi, Álvaro Ruiz-Granados, Guillermo Velasco
Publikováno v:
de Velasco, G, Ruiz-Granados, Á, Reig, O, Massari, F, Climent Duran, M A, Verzoni, E, Graham, J, Llarena, R, De Tursi, M, Donskov, F, Iglesias, C, Pandha, H S, Garcia del Muro, X, Procopio, G, Oudard, S, Castellano, D & Albiges, L 2021, ' Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib ', BJU International, vol. 128, no. 2, pp. 254-261 . https://doi.org/10.1111/bju.15356
Objective: To assess the efficacy and tolerability of rechallenge with sunitinib and other targeted therapies (TTs) in patitents with relapsed recurrent renal cell carcinoma (RCC) in the advanced setting. Methods: In this multi-institutional retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72473aeea45c3d54e46203620a189fb4
https://pure.au.dk/portal/da/publications/outcomes-of-systemic-targeted-therapy-in-recurrent-renal-cell-carcinoma-treated-with-adjuvant-sunitinib(3098a5ed-8db2-42a4-8864-f7fa0850dc6d).html
https://pure.au.dk/portal/da/publications/outcomes-of-systemic-targeted-therapy-in-recurrent-renal-cell-carcinoma-treated-with-adjuvant-sunitinib(3098a5ed-8db2-42a4-8864-f7fa0850dc6d).html